Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
55
NTRA Quote, Financials, Valuation and Earnings
Last price:
$231.97
Seasonality move
:
-2.23%
Day range:
$224.74 - $232.39
52-week range:
$125.38 - $246.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.79x
P/B ratio:
25.83x
Volume:
2.2M
Avg. volume:
1.6M
1-year change:
46.73%
Market cap:
$32.3B
Revenue:
$1.7B
EPS (TTM):
-$2.28
Analysts' Opinion
-
Consensus RatingNatera, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $244.42, Natera, Inc. has an estimated upside of 5.37% from its current price of $231.96.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $186.00 representing 100% downside risk from its current price of $231.96.
Fair Value
-
According to the consensus of 14 analysts, Natera, Inc. has 5.37% upside to fair value with a price target of $244.42 per share.
NTRA vs. S&P 500
-
Over the past 5 trading days, Natera, Inc. has underperformed the S&P 500 by -0.1% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Natera, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Natera, Inc. has grown year-over-year revenues for 34 quarters straight. In the most recent quarter Natera, Inc. reported revenues of $592.2M.
Earnings Growth
-
Natera, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Natera, Inc. reported earnings per share of -$0.64.
Enterprise value:
31.5B
EV / Invested capital:
21.71x
Price / LTM sales:
14.79x
EV / EBIT:
--
EV / Revenue:
14.88x
PEG ratio (5yr expected):
-3.53x
EV / Free cash flow:
336.70x
Price / Operating cash flow:
334.51x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$1.3B
Return On Assets:
-18%
Net Income Margin (TTM):
-14.61%
Return On Equity:
-26.6%
Return On Invested Capital:
-21.88%
Operating Margin:
-16.48%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $988.7M | $1.5B | $2.1B | $439.8M | $592.2M | |
| Gross Profit | $422.8M | $883.4M | $1.3B | $271.7M | $384.4M | |
| Operating Income | -$503.5M | -$242.1M | -$351.9M | -$39.3M | -$97.6M | |
| EBITDA | -$467.6M | -$204.9M | -$314.7M | -$31.1M | -$87.3M | |
| Diluted EPS | -$4.51 | -$1.77 | -$2.28 | -$0.26 | -$0.64 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.2B | $829.6M | $1.3B | $1.3B | $1.4B | |
| Total Assets | $1.3B | $1B | $1.4B | $1.6B | $1.8B | |
| Current Liabilities | $199.7M | $267.3M | $289.9M | $301.4M | $442M | |
| Total Liabilities | $552.4M | $647.5M | $661.9M | $712.4M | $569.3M | |
| Total Equity | $759M | $361.6M | $784.7M | $878.5M | $1.3B | |
| Total Debt | $328.5M | $359.8M | $350.9M | $385.5M | $104.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$270M | $24.7M | $194.3M | $51.8M | $59.4M | |
| Cash From Investing | $165.8M | $173.4M | -$71.7M | $42.5M | -$19.9M | |
| Cash From Financing | $715.8M | $26.1M | $26M | $1.7M | $1.9M | |
| Free Cash Flow | -$311.5M | -$43.7M | $93.6M | $25M | $24.5M | |
NTRA
Sector
Market Cap
$32.3B
$27.9M
Price % of 52-Week High
93.95%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
0.1%
-1.49%
1-Year Price Total Return
46.73%
-16.66%
Beta (5-Year)
1.628
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$229.27
200-day SMA
Buy
Level
$169.97
Bollinger Bands (100)
Buy
Level
157.52 - 216.58
Chaikin Money Flow
Buy
Level
115.4M
20-day SMA
Sell
Level
$234.31
Relative Strength Index (RSI14)
Buy
Level
58.40
ADX Line
Buy
Level
24.6
Williams %R
Neutral
Level
-59.6169
50-day SMA
Buy
Level
$210.92
MACD (12, 26)
Buy
Level
4.64
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
100.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (24.8338)
Buy
CA Score
(Annual)
Level (-0.1104)
Buy
Beneish M-Score
(Annual)
Level (-2.7237)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.118)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Stock Forecast FAQ
In the current month, NTRA has received 12 Buy ratings 2 Hold ratings, and 0 Sell ratings. The NTRA average analyst price target in the past 3 months is $244.42.
-
Where Will Natera, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Natera, Inc. share price will rise to $244.42 per share over the next 12 months.
-
What Do Analysts Say About Natera, Inc.?
Analysts are divided on their view about Natera, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Natera, Inc. is a Sell and believe this share price will drop from its current level to $186.00.
-
What Is Natera, Inc.'s Price Target?
The price target for Natera, Inc. over the next 1-year time period is forecast to be $244.42 according to 14 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is NTRA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Natera, Inc. is a Buy. 12 of 14 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NTRA?
You can purchase shares of Natera, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Natera, Inc. shares.
-
What Is The Natera, Inc. Share Price Today?
Natera, Inc. was last trading at $231.97 per share. This represents the most recent stock quote for Natera, Inc.. Yesterday, Natera, Inc. closed at $231.96 per share.
-
How To Buy Natera, Inc. Stock Online?
In order to purchase Natera, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NTRA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NTRA
Sector
P/E ratio
--
23.85x
PEG ratio
-3.53x
-0.01x
P/B ratio
25.83x
1.81x
Price / LTM sales
14.79x
1.58x
Growth Metrics
NTRA
Sector
Revenue growth
34.66%
4.62%
Earnings growth
-150.04%
10.5%
Revenue (5-year growth)
41.2%
6.5%
Earnings forecast
-$0.35
-$0.21
Profitability
NTRA
Sector
Profitability FY 2024
$1B
$3.6M
Return on invested capital
-21.88%
-31.87%
Return on assets
-18%
-28.18%
Return on equity
-26.6%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
NTRA
Sector
Total cash
$1B
$26.4M
Short term investments
$22.7M
$25.7M
Total assets
$1.7B
$76.9M
Long term debt
$104.4M
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
